- Home
- PCYO vs HRTX Comparison
PCYO vs HRTX Comparison
Compare PCYO & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCYO | HRTX |
|---|---|---|
| Founded | 1976 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 279.0M | 265.9M |
| IPO Year | 1995 | 2007 |
Fundamental Metrics
Financial Performance| Metric | PCYO | HRTX |
|---|---|---|
| Price | $10.24 | $0.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 54.5K | ★ 1.7M |
| Earning Date | 04-16-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.50 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | $1,227,787.00 | ★ $154,904,000.00 |
| Revenue This Year | N/A | $15.28 |
| Revenue Next Year | N/A | $20.29 |
| P/E Ratio | $54.42 | ★ N/A |
| Revenue Growth | ★ 171.54 | 7.36 |
| 52 Week Low | $9.65 | $1.00 |
| 52 Week High | $12.16 | $2.61 |
Technical Indicators
Market Signals| Indicator | PCYO | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 37.63 | 29.83 |
| Support Level | $9.90 | N/A |
| Resistance Level | $10.65 | $1.36 |
| Average True Range (ATR) | 0.36 | 0.09 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 7.92 | 6.37 |
Price Performance
Historical ComparisonAbout PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.